Patents Assigned to Modern Cell & Tissue Technologies, Inc.
  • Patent number: 8257973
    Abstract: The present invention relates to a method for co-culture of stem cells using feeder cells, more particularly to a method for culturing stem cells by using a membrane having a number of pores to separate stem cells and feeder cells. In the present invention, the culture condition of stem cells optimized is provided, in which stem cells and feeder cells are cultivated independently in separate spaces while permeating essential substances selectively. The stem cells prepared in the present invention continue to remain indifferent and be supported by feeder cells until needing being sub-cultured. In addition, the stem cells even for therapeutic use can be obtained without any contaminant since not pretreated with a cytostatic agent such as mitomycin or irradiated. Therefore, the method for co-culturing stem cells by using a membrane of the present invention can be widely used for clinical applications.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: September 4, 2012
    Assignee: Modern Cell & Tissue Technologies, Inc.
    Inventors: Hyun Sook Park, Sun Ray Lee
  • Publication number: 20110256089
    Abstract: Disclosed is a hydrogel type cell delivery vehicle composition for wound healing and to a preparation method thereof. More particularly, the present invention relates to a hydrogel type cell delivery vehicle composition in which non-ionic surfactants, growth factors or substance-P, human-derived cells, and the like are distributed in aqueous media, to a use thereof for wound healing, and to a preparation method thereof. The hydrogel type composition of the present invention appropriately delivers cells and/or substance-P to the wound part, and has moistening effects, effects of preventing contraction of the wound, and effects of protecting cells, and can be used in an easy and convenient manner. The cells in the composition are delivered to the wound part to effectively heal the wound when the composition of the present invention is applied to or injected into the wounded body part.
    Type: Application
    Filed: November 3, 2009
    Publication date: October 20, 2011
    Applicant: MODERN CELL & TISSUE TECHNOLOGIES INC.
    Inventors: Sae-Hwan Lim, Yun Young Kim, So Hee Yun
  • Publication number: 20100098671
    Abstract: Disclosed herein are a composition for prevention or treatment of bone marrow damage comprising Substance-P as an active ingredient; a use of Substance-P for the preparation of a medicament for prevention or treatment of bone marrow damage; a method for prevention or treatment of bone marrow damage comprising administering a therapeutically effective amount of Substance-P to a mammal; an anticancer supplement comprising Substance-P as an active ingredient; a use of Substance-P for the preparation of an anticancer supplement; and a method for prevention or treatment of cancer comprising administering a therapeutically effective amount of Substance-P as an anticancer supplement to a mammal. Substance-P stimulates proliferation of mesenchymal stem cells (MSCs) within the bone marrow to thereby facilitate protection and regeneration of bone marrow cells and hematopoietic stem cells.
    Type: Application
    Filed: June 7, 2007
    Publication date: April 22, 2010
    Applicants: MODERN CELL & TISSUE TECHNOLOGIES INC., KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Youngsook Son, Hyunsook Hong, Jungsun Lee
  • Publication number: 20100075418
    Abstract: The present invention relates to a method for co-culture of stem cells using feeder cells, more particularly to a method for culturing stem cells by using a membrane having a number of pores to separate stem cells and feeder cells. In the present invention, the culture condition of stem cells optimized is provided, in which stem cells and feeder cells are cultivated independently in separate spaces while permeating essential substances selectively. The stem cells prepared in the present invention continue to remain indifferent and be supported by feeder cells until needing being sub-cultured. In addition, the stem cells even for therapeutic use can be obtained without any contaminant since not pretreated with a cytostatic agent such as mitomycin or irradiated. Therefore, the method for co-culturing stem cells by using a membrane of the present invention can be widely used for clinical applications.
    Type: Application
    Filed: May 29, 2007
    Publication date: March 25, 2010
    Applicants: MODERN CELL & TISSUE TECHNOLOGIES, INC.
    Inventor: Hyun Sook Park